Medis

We are a fully integrated commercialization company focused on bringing life-changing therapies to patients in Central and Eastern Europe and Greece. As we proudly celebrate our 35th anniversary, we demonstrate a strong reputation in the region and established partnerships with some of the world’s leading pharmaceutical and biotech companies. Despite the region's challenging healthcare systems and complex markets, our team of 400 employees leverages its expertise and strong relationships with local healthcare professionals to ensure health equity in this often-overlooked region by global pharmaceutical companies. Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for rare and specialty portfolios. WODA covers 158 countries, offering unique commercial platform for the most extensive global coverage. Our business areas: • Therapeutics • Hospital Care • Consumer Health • Aesthetics Our value to partners: • Full commercialization services • Experienced market access, medical, sales, marketing, and regulatory teams • Single point of contact for 18 markets • Expertise in overcoming regional complexities and reimbursement barriers • Close relationships with local KOLs for fast market penetration • Highest ethical and compliance standards • Financial and credit excellence Major Partners: • Therapeutics: Bial – Biogen – Besins – Esteve – HRA Pharma – Italfarmaco –Mundipharma – Pierre Fabre – Santen – UCB • Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Enovis – Gaumard – Loccioni – Optiplan – Paion • Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO • Aesthetics: Merz Aesthetics – Crown Aesthetics • Out-licensing partners: Ferrer – Menarini – Pharmalink – Sarantis – Stada